Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Add each solvent one by one: 10% DMSO 90% (20% SBE--CD in Saline) Solubility: 2.5 mg/mL (1.76 mM)
Approximate Vial Duration One vial lasts approximately: 15 days at twice-daily administration Approximately 3 weeks at 5 weekly administration Important Research Considerations Most experimental research protocols commonly remain within: 2.3mg once daily Higher-frequency protocols may increase: Local sensitivity Administration-site irritation Response variability Individual sensitivity-related observations Additional Research Support Many research protocols commonly include: Daily zinc supplementation Daily vitamin C supplementation alongside Glow Blend research protocols
Supplied lyophilized for laboratory research use only
You specifically want FDA-approved medications rather than compounded formulations, since the brand states plainly that compounded medications are not FDA-approved and are not reviewed by FDA before marketing
It was identified through a medicinal chemistry programme at the University of Texas Health Science Center as the lead NNMT inhibitor candidate among a series of 1-methylquinolinium analogues bearing primary amine substitutions, selected for its combination of high passive membrane permeability (confirmed in PAMPA assays), high active transport membrane permeability (confirmed in bidirectional Caco-2 cell assays), potent NNMT inhibitory activity, and high selectivity including confirmed absence of inhibitory effects on related SAM-dependent methyltransferases or enzymes in the NAD+ salvage pathway
US$ 25.31
US$ 27.39
US$ 26.46
US$ 27.35
US$ 27.54
US$ 26.10
